This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Benedict, R H. Articles by Weinstock-Guttman, B Search for Related Content PubMed PubMed Citation Articles by Benedict, R H. Articles by Weinstock-Guttman, B Social Bookmarking                         What's this?

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis

Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA, Buffalo Neuroimaging Analysis Center, Buffalo, New York, USA, benedict{at}buffalo.cdu

I Fishman

Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA

M M McClellan

Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA

R Bakshi

Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA, Buffalo Neuroimaging Analysis Center, Buffalo, New York, USA, Imaging Services at Kaleida Health, Buffalo, New York, USA

B Weinstock-Guttman

Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA

Introduction: The Beck Depression Inventory-Fast Screen (BDI-FS) is a brief self-report inventory designed to evaluate depression in patients with medical illness. A s depressive disorder is especially prominent in multiple sclerosis (MS), a cost-effective procedure for identifying depressive disorder in MS is sorely needed. The BDI-FS may be useful in this regard although, to date, its validity in MS patients has not been assessed. Methods: Fifty-four consecutive MS patients were studied. A ll underwent psychological assessment, which included the BDI-FS and other self-report measures of depression. Forty-eight caregiver/informants were interviewed using the Neuorpsychiatric Inventory (NPI). Retrospective chart reviews were conducted by a single trained research assistant, blind to the results of psychological testing and interviews, to determine if antidepressant medications had been prescribed. Results: The BDI-FS was significantly correlated with other self-report measures of depression (P B-0.001) and with informant reported dysphoria (P B-0.01), In addition, BDI-FS scores discriminated MS patients undergoing treatment for depressive disorder from untreated MS patients (P =0.01). Conclusion: These data support the concurrent and discriminative validity of the BDI-FS in MS. A s the test is brief and not confounded with neurological symptoms, it is recommended for depression screening in this population.

Key Words: brief assessment • depression • discriminative validity • multiple sclerosis

Multiple Sclerosis, Vol. 9, No. 4, 393-396 (2003)
DOI: 10.1191/1352458503ms902oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L Strober, J Englert, F Munschauer, B Weinstock-Guttman, S Rao, and R. Benedict Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS Multiple Sclerosis, September 1, 2009; 15(9): 1077 - 1084. [Abstract] [PDF]

				S. Morrow, B Weinstock-Guttman, F. Munschauer, D Hojnacki, and R. Benedict Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis Multiple Sclerosis, August 1, 2009; 15(8): 998 - 1005. [Abstract] [PDF]

				R H B Benedict, D Ramasamy, F Munschauer, B Weinstock-Guttman, and R Zivadinov Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy J. Neurol. Neurosurg. Psychiatry, February 1, 2009; 80(2): 201 - 206. [Abstract] [Full Text] [PDF]

				S Vanotti, R. Benedict, L Acion, F Caceres, and and VANEM Workgroup Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina Multiple Sclerosis, February 1, 2009; 15(2): 244 - 250. [Abstract] [PDF]

				R. Benedict, J. Duquin, S Jurgensen, R. Rudick, J Feitcher, F. Munschauer, M. Panzara, and B Weinstock-Guttman Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire Multiple Sclerosis, August 1, 2008; 14(7): 940 - 946. [Abstract] [PDF]

				M. K. Houtchens, R.H.B. Benedict, R. Killiany, J. Sharma, Z. Jaisani, B. Singh, B. Weinstock-Guttman, C. R.G. Guttmann, and R. Bakshi Thalamic atrophy and cognition in multiple sclerosis Neurology, September 18, 2007; 69(12): 1213 - 1223. [Abstract] [Full Text] [PDF]

				R. H.B. Benedict, J. Bruce, M. G. Dwyer, B. Weinstock-Guttman, C. Tjoa, E. Tavazzi, F. E. Munschauer, and R. Zivadinov Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis Multiple Sclerosis, July 1, 2007; 13(6): 722 - 730. [Abstract] [PDF]

				D C Mohr, S L Hart, L Julian, and E S Tasch Screening for depression among patients with multiple sclerosis: two questions may be enough Multiple Sclerosis, March 1, 2007; 13(2): 215 - 219. [Abstract] [PDF]

				B A Parmenter, B Weinstock-Guttman, N Garg, F Munschauer, and R H. Benedict Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test Multiple Sclerosis, January 1, 2007; 13(1): 52 - 57. [Abstract] [PDF]

				R. H. B. Benedict, J. M. Bruce, M. G. Dwyer, N. Abdelrahman, S. Hussein, B. Weinstock-Guttman, N. Garg, F. Munschauer, and R. Zivadinov Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol, September 1, 2006; 63(9): 1301 - 1306. [Abstract] [Full Text] [PDF]

				F A H van der Linden, J J Kragt, M Klein, H M van der Ploeg, C H Polman, and B M J Uitdehaag Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1677 - 1681. [Abstract] [Full Text] [PDF]

				R J Siegert and D A Abernethy Depression in multiple sclerosis: a review J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 469 - 475. [Abstract] [Full Text] [PDF]

				R. H. Benedict, D. Cox, L. L Thompson, F. Foley, B. Weinstock-Guttman, and F. Munschauer Reliable screening for neuropsychological impairment in multiple sclerosis Multiple Sclerosis, December 1, 2004; 10(6): 675 - 678. [Abstract] [PDF]